The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow COO
The Cooper Companies, Inc. (COO) P/E ratio
As of 16 October 2026, The Cooper Companies, Inc. (COO) trades at a P/E ratio of 19.8×. Over the past ten years it has ranged from 6.3× (December 2021) to 110× (October 2018); the current reading is higher than 12% of that period. That is below the Medical Instruments & Supplies industry median of 33.8× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 37.2× | (30.73%) |
| FY2024 | 53.7× | 1.76% |
| FY2023 | 52.8× | 49.73% |
| FY2022 | 35.2× | 394.73% |
| FY2021 | 7.1× | (89.31%) |
| FY2020 | 66.6× | 113.88% |
| FY2019 | 31.2× | (66.47%) |
| FY2018 | 92.9× | 190.81% |
| FY2017 | 32.0× | 1.46% |
| FY2016 | 31.5× | (15.76%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jul 2026 | 24.7× | (53.70%) |
| Apr 2026 | 53.3× | 33.51% |
| Jan 2026 | 39.9× | 7.37% |
| Oct 2025 | 37.2× | 6.79% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BAX Baxter International Inc. compare | n/m |
| BLCO Bausch + Lomb Corporation compare | n/m |
| AVTR Avantor, Inc. compare | n/m |
| TFX Teleflex Incorporated compare | n/m |
| SOLV Solventum Corporation compare | 10.4× |
| COO The Cooper Companies, Inc. | 19.8× |
| ATR AptarGroup, Inc. compare | 22.2× |
| ALGN Align Technology, Inc. compare | 25.6× |
| RGEN Repligen Corporation compare | 234× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on COO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement